The KBO register currently lists the legal status of BIOTECH-SANCE as dissolution or liquidation, with no start date. The 2025 annual accounts show negative equity (-€497,456) and a net result of -€782.
Signalsraises riskRegister: dissolution or liquidationNegative equityAdministrative warnings in the KBO publicationsneutralFiled after the deadlineShow the evidence
Signals
Four signals.
raises riskneutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 27-12-2025, 57 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 795 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
raises risk · Administrative warnings in the KBO publications
1 publication by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or its withdrawal.